Veracyte, Inc. (VCYT) has 20 known insider and institutional holders on record. The largest holder is Stapley Marc with 449,653 shares. Other notable holders include Chambers Rebecca and Febbo Phillip G..
Over the last 12 months, insiders have made 73 transactions in VCYT stock — 15 buys (valued at RSU Award) and 26 sells (valued at $5.4M). Insider selling has exceeded buying during this period.
VCYT Insider Ownership
Top Holder
Stapley Marc
449,653 shares
Buys (12 mo)
15
$0.00 value
Sells (12 mo)
26
$5.4M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Stapley Marc |
Chief Executive Officer |
449,653 |
2026-03-10 |
|
| 2 |
Chambers Rebecca |
Chief Financial Officer |
167,377 |
2026-03-10 |
|
| 3 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
146,949 |
2026-03-10 |
|
| 4 |
Leite John |
Chief Commercial Officer-clia |
143,761 |
2026-03-10 |
|
| 5 |
Mcguire Annie |
SVP, General Counsel |
127,598 |
2026-03-10 |
|
| 6 |
Kennedy Keith |
COO / CFO |
116,858 |
2021-03-04 |
|
| 7 |
Nova Tina Susan |
President, Clia U.s. |
76,988 |
2022-03-07 |
|
| 8 |
Epstein Robert S |
Director |
73,919 |
2025-06-23 |
|
| 9 |
Hanna John Walter Jr |
Chief Commercial Officer |
73,844 |
2020-12-04 |
|
| 10 |
Ho Mark |
Officer |
71,728 |
2021-03-04 |
|
| 11 |
Kennedy Giulia C |
Chief Scientific & Med Officer |
65,970 |
2022-12-08 |
|
| 12 |
Barr Eliav |
Director |
51,189 |
2025-06-23 |
|
| 13 |
Wygant Jonathan |
VP, Chief Accounting Officer |
45,434 |
2026-03-10 |
|
| 14 |
Anderson Bonnie H |
Director |
41,377 |
2023-06-06 |
|
| 15 |
Bhanji Muna |
Director |
39,310 |
2025-06-23 |
|
| 16 |
Jones Evan/ Fa |
Director |
29,362 |
2025-11-26 |
|
| 17 |
Hall Christopher M |
President and COO |
28,258 |
2019-06-05 |
|
| 18 |
Holstein Jens |
Director |
27,199 |
2025-11-21 |
|
| 19 |
Miller Thomas F. |
Director |
25,828 |
2025-06-23 |
|
| 20 |
Shafer David Brent |
Director |
25,828 |
2025-06-23 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-24 |
Haas Kevin Richard |
Officer |
Unknown |
- |
- |
- |
| 2026-03-06 |
Leite John |
Chief Commercial Officer-clia |
RSU Award |
36,181 |
- |
- |
| 2026-03-06 |
Mcguire Annie |
SVP, General Counsel |
RSU Award |
32,892 |
- |
- |
| 2026-03-06 |
Chambers Rebecca |
Chief Financial Officer |
RSU Award |
36,181 |
- |
- |
| 2026-03-06 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
RSU Award |
29,603 |
- |
- |
| 2026-03-06 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU Award |
10,525 |
- |
- |
| 2026-03-06 |
Stapley Marc |
Chief Executive Officer |
RSU Award |
92,099 |
- |
- |
| 2026-03-04 |
Leite John |
Chief Commercial Officer-clia |
Informative Sell |
5,260 |
$35.19 |
$185.08K |
| 2026-03-04 |
Mcguire Annie |
SVP, General Counsel |
Informative Sell |
1,664 |
$36.34 |
$60.47K |
| 2026-03-04 |
Chambers Rebecca |
Chief Financial Officer |
Informative Sell |
13,941 |
$36.33 |
$506.46K |
| 2026-03-04 |
Stapley Marc |
Chief Executive Officer |
Informative Sell |
26,279 |
$36.28 |
$953.37K |
| 2026-03-02 |
Leite John |
Chief Commercial Officer-clia |
Tax Withholding of RSU |
7,517 |
$36.01 |
$270.69K |
| 2026-03-02 |
Mcguire Annie |
SVP, General Counsel |
Tax Withholding of RSU |
6,902 |
$36.01 |
$248.54K |
| 2026-03-02 |
Chambers Rebecca |
Chief Financial Officer |
Tax Withholding of RSU |
7,234 |
$36.01 |
$260.5K |
| 2026-03-02 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
Informative Sell |
13,425 |
$36.16 |
$485.43K |
| 2026-03-02 |
Wygant Jonathan |
VP, Chief Accounting Officer |
Tax Withholding of RSU |
3,006 |
$36.01 |
$108.25K |
| 2026-03-02 |
Stapley Marc |
Chief Executive Officer |
Tax Withholding of RSU |
19,455 |
$36.01 |
$700.57K |
| 2026-02-26 |
Leite John |
Chief Commercial Officer-clia |
Tax Withholding of RSU |
8,905 |
$38.75 |
$345.07K |
| 2026-02-26 |
Mcguire Annie |
SVP, General Counsel |
Tax Withholding of RSU |
10,867 |
$38.75 |
$421.1K |
| 2026-02-26 |
Chambers Rebecca |
Chief Financial Officer |
Tax Withholding of RSU |
12,049 |
$38.75 |
$466.9K |
| 2026-02-26 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
Tax Withholding of RSU |
24,486 |
$38.75 |
$948.83K |
| 2026-02-26 |
Stapley Marc |
Chief Executive Officer |
Tax Withholding of RSU |
35,841 |
$38.75 |
$1.39M |
| 2025-12-16 |
Mcguire Annie |
SVP, General Counsel |
Informative Sell |
100 |
$43.68 |
$4.37K |
| 2025-12-05 |
Eastham Karin |
Director |
Option Exercise (Sell) |
10,000 |
$7.94 |
$79.4K |
| 2025-12-04 |
Leite John |
Chief Commercial Officer-clia |
Informative Sell |
1,278 |
$47.51 |
$60.72K |
